RAGE does not contribute to renal injury and damage upon ischemia/reperfusion-induced injury

The receptor for advanced glycation end products (RAGE) mediates a variety of inflammatory responses in renal diseases, but its role in renal ischemia/reperfusion (I/R) injury is unknown. We showed that during renal I/R, RAGE ligands HMGB1 and S100B are expressed. However, RAGE deficiency does not a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Dessing, Mark C. (VerfasserIn) , Nawroth, Peter Paul (VerfasserIn) , Bierhaus, Angelika (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2012
In: Journal of innate immunity
Year: 2012, Jahrgang: 4, Heft: 1, Pages: 80-85
ISSN:1662-8128
DOI:10.1159/000334251
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1159/000334251
Verlag, Volltext: https://www.karger.com/Article/FullText/334251
Volltext
Verfasserangaben:Mark C. Dessing, Wilco P. Pulskens, Gwendoline J. Teske, Loes M. Butter, Tom van der Poll, Huan Yang, Kevin J. Tracey, Peter P. Nawroth, Angelika Bierhaus, Sandrine Florquin, Jaklien C. Leemans
Beschreibung
Zusammenfassung:The receptor for advanced glycation end products (RAGE) mediates a variety of inflammatory responses in renal diseases, but its role in renal ischemia/reperfusion (I/R) injury is unknown. We showed that during renal I/R, RAGE ligands HMGB1 and S100B are expressed. However, RAGE deficiency does not affect renal injury and function upon I/R-induced injury.
Beschreibung: Published online: November 4, 2011
Gesehen am 11.12.2018
Beschreibung:Online Resource
ISSN:1662-8128
DOI:10.1159/000334251